Eris Lifesciences Cash Flow Annual

Trade
BSE: 540596 | NSE: ERIS | ISIN: INE406M01024 | Sector: Biotechnology & Drugs
1,467.45 +91.30 (6.63%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 431.24404.64442.20394.50
Depreciation/ Depletion 182.61117.0964.7142.99
Non- Cash Items 71.6622.75-15.451.09
Changesin Working Capital -199.49-245.25-113.19-63.21
Cashfrom Operating Activities 486.01299.23378.26375.36
Capital Expenditures -129.16-841.42-121.03-25.76
Other Investing Cash Flow Items Total -1,725.36-140.68-198.58-297.60
Cashfrom Investing Activities -1,854.52-982.10-319.61-323.36
Financing Cash Flow Items -87.58-23.43-3.32-1.78
Total Cash Dividends Paid 0.00-99.91-81.62-74.68
Issuance( Retirement)of Stock Net 4.542.286.750.00
Issuance( Retirement)of Debt Net 1,462.81809.0933.50-5.94
Cashfrom Financing Activities 1,379.78688.03-44.70-82.40
Net Changein Cash 11.265.1513.96-30.39
Cash Interest Paid 77.3023.433.851.78
Cash Taxes Paid 100.7577.2183.2968.54
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts